{"adverse event": 7.13, "agitation": 5.35, "akathisia": 85.11, "anxiety": 2.55, "disorientation": 6.82, "dysarthria": 13.57, "dysgeusia": 8.58, "dyskinesia": 9.82, "dysphagia": 3.54, "extrapyramidal disorder": 107.75, "generalised tonic-clonic seizure": 8.78, "hypoaesthesia oral": 18.43, "incorrect route of product administration": 27.97, "insomnia": 2.31, "neuroleptic malignant syndrome": 77.43, "off label use": 4.3, "parkinsonism": 58.35, "product use in unapproved indication": 2.21, "restlessness": 5.61, "rhabdomyolysis": 10.63, "schizophrenia": 50.36, "sedation": 65.03, "sedation complication": 107.51, "somnolence": 3.77, "suicidal ideation": 3.7, "suicide attempt": 10.15, "urinary retention": 7.16, "weight increased": 2.78}